Drug
Zp4207
Zp4207: highest development phase Phase 2, developed by Zealand Pharma. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZP4207 NCT02660008 | Phase 2 | Hypoglycemia |
| ZP4207 NCT02367053 | Phase 1 | Hypoglycemia |
| ZP4207 NCT02390141 | Phase 1 | Hypoglycemia |
Latest
No recent events.
Follow Zp4207 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.